Skip to main content
. 2019 Apr 30;4(1):e000226. doi: 10.1136/bmjophth-2018-000226

Table 4C.

Change in MacTSQ subscales between M1 (MacTSQ baseline) to M6, 12 and 18 in the subset of participants in whom at baseline the study eye was the ‘worse’ eye compared with the fellow eye in terms of BCVA letters

Change in MacTSQ subscales Mean 1 Mean 2 Difference 95% CI Significance
Subscale 1: information provision and convenience
Pair 1 (n=69)
Months 1–6
32.86 33.72 0.87 0.18 to 1.56 0.015
Pair 2 (n=70)
Subscale 1
Months 1–12
33.31 34.20 0.89 0.29 to 1.48 0.004
Pair 3 (n=67)
Months 1–18
33.24 34.04 0.81 0.08 to 1.54 0.031
Subscale 2: impact of treatment and treatment satisfaction
Pair 4 (n=70)
Months 1–6
28.87 31.20 2.59 1.56 to 3.62 <0.001
Pair 5 (n=70)
Months 1–12
29.57 32.34 3.47 2.46 to 4.48 <0.001
Pair 6 (n=67)
Months 1–18
28.73 32.67 3.94 2.81 to 5.10 <0.001

BCVA, best-corrected visual acuity; MacTSQ, Macular Disease Society Treatment Satisfaction Questionnaire.